Latest stories on BIIB
Why Biogen Stock Topped the Market Today
The Motley Fool68 · bullishearnings
Biogen outlines 2026 non-GAAP EPS $12-$13 and expects SYFOVRE and EMPAVELI mid- to high teens growth through at least 2028
Seeking Alpha63 · neutralearnings
Biogen Inc. (BIIB) Q2 2026 Earnings Call Transcript
Seeking Alpha50 · neutralearnings
Oppenheimer reiterates Biogen stock rating on strong quarter
Investing.com Analyst Ratings63 · neutralanalyst
Biogen: The Turnaround Is Real Enough To Buy (Rating Upgrade)
Seeking Alpha63 · neutralanalyst
Biogen beats quarterly estimates as newer drugs drive growth
Investing.com Markets68 · bullishearnings
Biogen Q2 Earnings Call Highlights
Yahoo Finance63 · neutralearnings
Biogen Inc. 2026 Q2 - Results - Earnings Call Presentation
Seeking Alpha50 · neutralearnings
Biogen Beats Second-Quarter Expectations as Growth Portfolio Drives Revenue Higher
InvestorsHub68 · bullishearnings
Stocks making the biggest moves premarket: Biogen, Vertiv, GE HealthCare, Generac & more
CNBC50 · neutralgeneral
Sales of Leqembi® totaled 29.3 billion yen in the second quarter 2026
PR Newswire50 · neutralgeneral
Biogen Cuts FY Adjusted View as Profit Declines
WSJ Business34 · bearishearnings
Biogen beats top-line and bottom-line estimates; updates FY26 outlook
Seeking Alpha71 · bullishearnings
BIOGEN INC. (BIIB) files 8-K
SEC 8-K50 · neutralgeneral
Biogen Raises Earnings Guidance as Growth Portfolio Outpaces Legacy Blockbuster Drugs
Barron's67 · bullishearnings
Biogen beats quarterly estimates as newer drugs fuel growth
Reuters68 · bullishearnings
Biogen Q2 2026 Earnings Preview
Seeking Alpha56 · neutralearnings
Biogen And The Limitation Of The Tau Approach To Alzheimer's Disease
Seeking Alpha42 · neutralproduct/pr
BofA cuts Biogen stock price target on higher expectations bar
Investing.com Analyst Ratings34 · bearishanalyst
Synapticure Launches Groundbreaking Ataxia Care Program, Expanding Access to Specialized Neurology Nationwide | BIIB Stock News
StockTitan63 · neutralproduct/pr
Biogen Inc. (BIIB) Presents at Alzheimer's Association International Conference (AAIC Meeting) 2026 Transcript
Seeking Alpha50 · neutralgeneral
Biogen’s Alzheimer’s Drug Leaves Questions Unanswered, and That’s a Problem
Barron's34 · bearishgeneral
BIIB Stock On Track For Worst Day In 2 Years After RBC Questions If Alzheimer’s Drug Benefits Will Replicate In Further Study
Stocktwits News28 · bearishearnings
Biogen stock sinks after Alzheimer's drug trial data fails to impress investors
Quartz28 · bearishearnings